Authors:
CALLIGARO DO
FAIRHURST J
HOTTEN TM
MOORE NA
TUPPER DE
Citation: Do. Calligaro et al., THE SYNTHESIS AND BIOLOGICAL-ACTIVITY OF SOME KNOWN AND PUTATIVE METABOLITES OF THE ATYPICAL ANTIPSYCHOTIC AGENT OLANZAPINE (LY170053), Bioorganic & medicinal chemistry letters, 7(1), 1997, pp. 25-30
Authors:
BYMASTER FP
RASMUSSEN K
CALLIGARO DO
NELSON DL
DELAPP NW
WONG DT
MOORE NA
Citation: Fp. Bymaster et al., IN-VITRO AND IN-VIVO BIOCHEMISTRY OF OLANZAPINE - A NOVEL, ATYPICAL ANTIPSYCHOTIC DRUG, The Journal of clinical psychiatry, 58, 1997, pp. 28-36
Authors:
MOORE NA
LEANDER JD
BENVENGA MJ
GLEASON SD
SHANNON H
Citation: Na. Moore et al., BEHAVIORAL PHARMACOLOGY OF OLANZAPINE - A NOVEL ANTIPSYCHOTIC DRUG, The Journal of clinical psychiatry, 58, 1997, pp. 37-44
Authors:
ONEILL MF
MOORE NA
DOBSON DR
STEGGLES D
CONWAY MW
Citation: Mf. Oneill et al., EFFECT OF ANTAGONISM OF 5-HT1A AND 5-HT1B RECEPTORS ON RESPONSE TO 5-HT1 RECEPTOR AGONISTS AND IMIPRAMINE IN THE FORCED SWIM TEST IN MICE, British Journal of Pharmacology, 122, 1997, pp. 294-294
Authors:
FUJIWARA H
MOORE NA
DZIELAK DJ
GROGAN JB
RAJU S
Citation: H. Fujiwara et al., LIGHT AND ELECTRON-MICROSCOPIC OBSERVATIONS OF EPITHELIAL, SHEDDING IN STORED CANINE SMALL-INTESTINE, Transplantation, 60(11), 1995, pp. 1322-1326
Citation: Na. Moore et al., EFFECTS OF OLANZAPINE AND OTHER ANTIPSYCHOTIC AGENTS ON RESPONDING MAINTAINED BY A CONFLICT SCHEDULE, Behavioural pharmacology, 5(2), 1994, pp. 196-202
Authors:
TARR TJ
MOORE NA
FRAZER RS
SHEARER ES
DESMOND MJ
Citation: Tj. Tarr et al., HEMODYNAMIC-EFFECTS AND COMPARISON OF ENOXIMONE, DOBUTAMINE AND DOPAMINE FOLLOWING MITRAL-VALVE SURGERY, European journal of anaesthesiology, 10, 1993, pp. 15-24
Citation: Na. Moore et al., 5-HT(1A)-MEDIATED LOWER LIP RETRACTION - EFFECTS OF 5-HT(1A) AGONISTSAND ANTAGONISTS, Pharmacology, biochemistry and behavior, 46(1), 1993, pp. 141-143
Citation: Na. Moore et al., EFFECT OF L-TYPE CALCIUM-CHANNEL MODULATORS ON STIMULANT-INDUCED HYPERACTIVITY, Neuropharmacology, 32(7), 1993, pp. 719-720
Citation: Na. Moore et al., NMDA RECEPTOR ANTAGONISTS INHIBIT CATALEPSY INDUCED BY EITHER DOPAMINE-D1 OR DOPAMINE-D2 RECEPTOR ANTAGONISTS, European journal of pharmacology, 237(1), 1993, pp. 1-7